Translational Modeling of Brain Injury Rehabilitation to Maximize Recovery.
脑损伤康复转化模型以最大限度地恢复。
基本信息
- 批准号:10183457
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcheAcuteAnimal ModelAnimalsAnisotropyAutopsyBlindedBloodBrainBrain InjuriesBrain MassBrain-Derived Neurotrophic FactorBranched-Chain Amino AcidsCaringChronicClinicalClinical ManagementClinical ResearchCognitionCognitive deficitsComaCommunitiesDataData CollectionDiagnosticDietary SupplementationDiffuseDiffuse Axonal InjuryDiffusion Magnetic Resonance ImagingDoctor of PhilosophyElectrophysiology (science)EnrollmentEnvironmentEtiologyEvaluationExerciseFamily suidaeFatigueFoundationsFrequenciesFutureGaitGeneral PopulationGoalsHeadHistopathologyHumanImmunohistochemistryIndividualInjuryInterventionInvestigationInvestmentsK-Series Research Career ProgramsKnowledgeLifeLongitudinal StudiesMedical centerMentorsMentorshipMissionModelingMonitorNerve DegenerationNervous System TraumaNeurologicOutcomeOutputPathologyPathway interactionsPatientsPennsylvaniaPhasePhiladelphiaPhysical ExercisePlacebosPre-Clinical ModelProtocols documentationRandomizedRecoveryRecovery of FunctionRehabilitation therapyResearchResearch PersonnelResolutionResourcesRodent ModelRotationSample SizeSerumServicesSeveritiesSignal TransductionSleepSleep DeprivationSleep disturbancesSliceStructureSystemTestingTherapeuticTimeTranslationsTraumatic Brain InjuryTraumatic Brain Injury recoveryUnconscious StateUnit of MeasureUniversitiesVeteransactigraphyamino acid therapybrain sizecareerclinically relevantcognitive enhancementcognitive recoverycognitive testingdiet and exercisedietarydriving forceeffective therapyefficacy testingexercise rehabilitationexperienceimprovedin vivointerestlong-term rehabilitationmembermilitary veteranmultimodalityneurobehavioralneuroimagingneurological rehabilitationneuroprotectionnovel therapeuticspatient variabilityporcine modelpre-clinicalprognosticrehabilitation researchrehabilitation strategyresearch and developmentrestorationsevere injurysleep qualitytherapeutic targettherapy developmenttractographytranslational modeltreadmilltreatment group
项目摘要
The motivating force driving me to build an independent research enterprise has been my personal desire to
maximize functional recovery after traumatic brain injury (TBI). Experiences in my life have solidified this
research goal as one of primary purpose, and my career trajectory and accomplishments through adversity
stand as evidence of my devotion to that purpose and ability to acheive it. This mission brought me to the
Philadelphia CMC VA Medical Center (CMC-VAMC), where I have found that my own research goals align
perfectly with those of the Rehabilitation R&D (RR&D) Service and the needs of our Veterans. To make the
greatest impact on TBI rehabilitation, I will utilize a unique large animal model to accurately replicate the
mechanisms and manifestations of human TBI: the swine rotational acceleration system applied to great effect
by my mentor, D. Kacy Cullen, PhD, and other researchers in his Center for Neurotrauma, Neurodegeneration,
and Restoration at the CMC-VAMC and University of Pennsylvania. In addition to diffuse axonal injury, this
model results in damage to the ascending reticular activating system (ARAS) as observed in moderate TBI in
humans, leading to temporary loss of consciousness and lasting effects on sleep, fatigue, and cognition that are
major factors during recovery from TBI. Due to their small brain size, our commonly used rodent models
cannot be used to reproduce these aspects of the human injury or their manifestations, as the damage is a
product of rotational acceleration and brain mass. In this project I propose to build on the swine model,
extending beyond the acute injury period following moderate TBI to establish the first translational model of
moderate TBI Rehabilitation and Recovery at long-term time points most relevant for our Veteran population.
Such a high-fidelity preclinical model will provide the rigor and control necessary to directly test the efficacy of
individual ingredients of rehabilitation therapies (e.g. diet, exercise) and conduct detailed mechanistic
investigations to inform adjustments to existing therapies and development of new therapies that improve
efficacy. I will christen this vessel of bidirectional translation with a blinded, randomized investigation of the
efficacy and mechanisms of action of dietary branched-chain amino acid (BCAA) therapy for enhancing
cognitive recovery over a three-month study period (including investigation of Veteran-relevant delayed therapy
administration). Our studies will benefit greatly from clinically-relevant advanced neuroimaging, a gamut of
clinically-inspired neurobehavioral and neurological testing, extensive histopathological and
immunohistochemical analyses, and high-resolution post-mortem diffusion tensor imaging with anisotropy,
diffusivity, and tractography to quantify changes in brain connectivity that are a hallmark of human TBI. I will
also utilize this model to test the mechanisms and efficacy of regular exercise rehabilitation or exercise plus
BCAAs for improving recovery trajectory over a six-month period (also with Veteran-relevant delayed
treatment). Previous studies suggest that exercise and BCAA therapies share common mechanisms of action
and effects, and therefore I will effectively be testing the overarching hypothesis that enhancing neurotrophic
signaling and improving sleep quality after injury can improve cognitive recovery and reduce ARAS pathology
following moderate TBI. Beyond the advancements that this project will provide for our mission to maximize
functional recovery from brain injury in our Veterans, I will be gathering invaluable knowledge and expertise
from a dedicated, world-class mentorship team and carving a niche for my future career as an independent VA
investigator. Due to the swine model and the community of researchers gathered around it, the CMC-VAMC
and University of Pennsylvania are at the epicenter of translational TBI research. The greatest environment in
the world to achieve my research goals in TBI rehabilitation is within this community, and I intend to become an
integral member throughout my career. I will achieve independence through this Career Development Award
and provide considerable return on investment through a highly productive VA research career.
推动我建立一家独立研究企业的动力一直是我个人的愿望
最大限度地恢复创伤性脑损伤(TBI)后的功能。我生活中的经历巩固了这一点
将研究目标作为首要目标之一,以及我在逆境中的职业轨迹和成就
作为我对这一目标的忠诚和实现它的能力的证据。这次任务把我带到了
费城CMC VA医疗中心(CMC-VAMC),在那里我发现我自己的研究目标是一致的
完全符合康复研发(RR&D)服务和退伍军人的需求。要使
最大的影响,我将利用一个独特的大型动物模型准确地复制
人脑损伤的机制与表现:猪旋转加速系统应用效果显著
由我的导师D·凯西·库伦博士和他的神经创伤、神经退行性变中心的其他研究人员撰写,
以及在CMC-VAMC和宾夕法尼亚大学的修复。除了弥漫性轴突损伤,这一点
模型导致上行网状激活系统(ARAS)损伤,在中度脑损伤中观察到
人类会暂时失去知觉,并对睡眠、疲劳和认知产生持久的影响
影响颅脑损伤康复的主要因素。由于它们的大脑很小,我们常用的啮齿动物模型
不能用来再现人类伤害的这些方面或其表现形式,因为损害是
旋转加速度和脑质量的乘积。在这个项目中,我建议建立在猪模型的基础上,
延缓中度颅脑损伤后急性损伤期建立首个脑损伤模型
在与我们的退伍军人人口最相关的长期时间点进行适度的TBI康复和恢复。
这种高保真的临床前模型将提供必要的严谨和控制,以直接测试
康复治疗的个别成分(例如饮食、运动),并进行详细的机械操作
为现有疗法的调整和改善的新疗法的开发提供信息的调查
功效。我将用一项盲目的、随机的调查来命名这艘双向翻译的船
膳食支链氨基酸(BCAA)治疗增强剂的疗效及作用机制
为期三个月的认知恢复(包括对退伍军人相关延迟治疗的调查
行政管理)。我们的研究将极大地受益于临床相关的先进神经成像,一系列
临床启发的神经行为和神经测试,广泛的组织病理学和
免疫组织化学分析和具有各向异性的高分辨率死后扩散张量成像,
弥散性,以及脑束成像,以量化脑连接的变化,这是人类脑损伤的标志。这就做
也利用这个模型来测试定期运动康复或运动加运动的机制和效果。
在六个月内改善复苏轨迹的BCAA(与退伍军人相关的也有延迟
治疗)。先前的研究表明,运动疗法和支链氨基酸疗法具有共同的作用机制
和效果,因此我将有效地检验增强神经营养的首要假设
损伤后信号和改善睡眠质量可以改善认知恢复和减少ARAS病理
在中度脑外伤后。除了这个项目将为我们的使命提供的进步之外,最大限度地
从我们的退伍军人脑损伤中恢复功能,我将收集宝贵的知识和专业知识
来自一支敬业的世界级导师团队,为我未来的独立退伍军人职业生涯开辟了一个利基市场
调查员。由于猪模型和聚集在它周围的研究人员社区,CMC-VAMC
和宾夕法尼亚大学都处于翻译TBI研究的中心。中国最好的环境
实现我的脑外伤康复研究目标的世界就在这个社区内,我打算成为一名
在我整个职业生涯中都是不可或缺的一员。我将通过这个职业发展奖实现独立
并通过高效的退伍军人管理局研究生涯提供可观的投资回报。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Charles O'Donnell其他文献
John Charles O'Donnell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Charles O'Donnell', 18)}}的其他基金
Translational Modeling of Brain Injury Rehabilitation to Maximize Recovery.
脑损伤康复转化模型以最大限度地恢复。
- 批准号:
10557786 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Translational Modeling of Brain Injury Rehabilitation to Maximize Recovery.
脑损伤康复转化模型以最大限度地恢复。
- 批准号:
10341226 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Mitochondrial dynamics in astrocytic processes after transient ischemia
短暂性缺血后星形胶质细胞过程中的线粒体动力学
- 批准号:
8921078 - 财政年份:2014
- 资助金额:
-- - 项目类别:
相似国自然基金
转录因子BMAL1调控AChE在昼夜节律紊乱致认知损害中的作用及分子机制
- 批准号:2024Y9230
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
基于无机基质固定碳点光学探针研究有机磷农药暴露AChE响应的活体测量
- 批准号:
- 批准年份:2024
- 资助金额:50 万元
- 项目类别:面上项目
基于AChE/NLRP3 靶点研究垂穗石松中抗AD新型黄酮苷
吐星酸酯类成分的发现及作用机制研究
- 批准号:2024JJ8138
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于GSK-3β/AChE双重抑制的抗AD杂交分子的设计、合成及作用机制研究
- 批准号:22367005
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于可逆界面传质调控机制的AChE固定化荧光传感器及有机磷农药高灵敏抗干扰速测
- 批准号:32372427
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
利用微流体技术合成富缺陷MOFs材料定向捕获AChE酶构筑高性能传感界面
- 批准号:32302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗基质干扰导向的AChE仿生荧光探针的设计合成及农药残留速测应用
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于高分辨活性轮廓分析的中药AChE/GSK3β双靶点抑制剂高内涵筛选研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型AChE/NLRP3双靶点抑制剂—藤石松中抗AD新颖黄酮苷吐星酸酯类成分的发现及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于AchE靶点的苗药三两银抗阿尔兹海默症甾体生物碱类化合物发现与作用机制研究
- 批准号:82260833
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
AchE阻害活性アルカロイドの骨格生合成酵素の機能解析と改変
具有AchE抑制活性的生物碱骨架生物合成酶的功能分析及修饰
- 批准号:
23K24040 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Research to create homoisoflavonoid analogues with both AChE inhibitory and neurite outgrowth promoting activities.
研究创建具有乙酰胆碱酯酶抑制和神经突生长促进活性的高异黄酮类似物。
- 批准号:
22K05458 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
AchE阻害活性アルカロイドの骨格生合成酵素の機能解析と改変
具有AchE抑制活性的生物碱骨架生物合成酶的功能分析及修饰
- 批准号:
22H02777 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Exploring reversible AChE inhibitors as a treatment for refractory epilepsies
探索可逆的 AChE 抑制剂治疗难治性癫痫
- 批准号:
9764633 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Towards continuous real-time acetylcholine esterase (AChE) monitoring using wearable sensors
使用可穿戴传感器进行连续实时乙酰胆碱酯酶 (AChE) 监测
- 批准号:
2520106 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Studentship
GCAMP6 mice for determination of mechanisms of chronic muscle ache, pain and fatigue
GCAMP6 小鼠用于确定慢性肌肉疼痛、疼痛和疲劳的机制
- 批准号:
9090636 - 财政年份:2016
- 资助金额:
-- - 项目类别:
GCAMP6 mice for determination of mechanisms of chronic muscle ache, pain and fatigue
GCAMP6 小鼠用于确定慢性肌肉疼痛、疼痛和疲劳的机制
- 批准号:
9260952 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Developing Cholinesterase (AChE) inhibitor screening methods using Nuclear Magnetic Resonance Spectroscopy (NMR)
使用核磁共振波谱 (NMR) 开发胆碱酯酶 (AChE) 抑制剂筛选方法
- 批准号:
1667863 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Studentship
Accelerated AChE Reactivator Design by Mechanistic Neutron Scattering Studies
通过机械中子散射研究加速乙酰胆碱酯酶再激活器设计
- 批准号:
8735548 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Accelerated AChE Reactivator Design by Mechanistic Neutron Scattering Studies
通过机械中子散射研究加速乙酰胆碱酯酶再激活器设计
- 批准号:
8892277 - 财政年份:2014
- 资助金额:
-- - 项目类别: